If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMADE.L Regulatory News (MADE)

  • There is currently no data for MADE

Director/PDMR Shareholding

29 Jun 2022 16:00

RNS Number : 6941Q
Made.com Group Plc
29 June 2022
 

29 June 2022

 

Made.com Group Plc

(the "Company")

Notification of Transactions by Directors/Persons Discharging Managerial Responsibilities

On 28 June 2022, the Company granted a Performance Share Plan award ("the Award") in the form of nil cost options over ordinary shares of Made.com Group Plc, under the Made.com Incentive Plan. The table below sets out the number of shares awarded to Patrick Lewis, Chief Financial Officer. The price used to determine the value of the Award was 49.7 pence per share, this being the Company's closing share price on 27 June 2022.

The Award will vest subject to the achievement of performance conditions, Patrick Lewis's continued employment over the vesting period and will be subject to a two-year post-vesting holding period. The following performance conditions apply to the Award:

· one quarter of the Award may vest subject to the achievement of gross sales growth performance;

· one quarter of the Award may vest subject to the achievement of the Company's Total Shareholder Return ("TSR") performance measured against TSR comparator groups;

· one quarter of the Award may vest subject to the achievement of earnings per share performance; and

· one quarter of the Award may vest subject to the achievement of Environmental, Social and Governance related measures.

The Remuneration Committee will have the discretion to adjust the Award outcomes if it believes that the outcome is not a fair and accurate reflection of business performance, which also includes consideration of any windfall gains. The exercise of this discretion may result in a downward or upward movement in the amount of the Award earned resulting from the application of the performance measures.

 

1

Details of the person discharging managerial responsibilities

a)

Name

Patrick Lewis

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer

a)

Name

Made.com Group Plc

b)

LEI

213800HTMSVK071K6071

4

Details of the transaction

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares with a nominal value of £0.0001 each

GB00BNXM7M46

b)

Nature of the transaction

Grant of nil cost options over ordinary shares under the Made.com Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 1,408,450

d)

Aggregated information

-

Aggregated volume

-

Price

 

 

1,408,450

Nil

e)

Date of the transaction

2022-06-28

f)

Place of the transaction

Outside a trading venue

 

 

Enquiries:

Meirion Morgan

Deputy Company Secretary

companysecretary@made.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFESREIAFIF
Date   Source Headline
21st Jun 202212:41 pmRNSBlock Listing Application
16th May 20227:01 amRNSDirectorate Change
16th May 20227:00 amRNSTrading Update
9th May 20227:00 amRNSAcquisition
5th May 20224:23 pmRNSResult of AGM
5th May 20228:30 amRNSDirectorate Change
11th Apr 202211:59 amRNSHolding(s) in Company
6th Apr 202212:43 pmRNSDirector/PDMR Shareholding
1st Apr 202212:25 pmRNSNotice of AGM
25th Mar 20227:00 amRNSDirectorate Change
17th Mar 202211:26 amRNSAnnual Financial Report
8th Mar 20227:00 amRNSPreliminary Results
28th Feb 202211:26 amRNSTotal Voting Rights
21st Feb 20227:00 amRNSDirectorate Change
31st Jan 202210:17 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSTrading Statement
31st Dec 20219:38 amRNSTotal Voting Rights
21st Dec 202110:31 amRNSBlock listing Interim Review
15th Dec 20213:31 pmRNSCompletion of Capital Reduction
9th Dec 20217:00 amRNSTrading Update
30th Nov 202111:01 amRNSTotal Voting Rights
29th Oct 202110:08 amRNSTotal Voting Rights
30th Sep 202110:07 amRNSTotal Voting Rights
14th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
31st Aug 202110:42 amRNSTotal Voting Rights
3rd Aug 20215:01 pmRNSHolding(s) in Company
30th Jul 202111:21 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSNotice of Half Year Results
30th Jul 20217:00 amRNSAppointment of Joint Corporate Brokers
23rd Jul 20212:46 pmRNSHolding(s) in Company
23rd Jul 20211:47 pmRNSHolding(s) in Company
16th Jul 20217:00 amRNSStabilisation Notice
16th Jul 20217:00 amRNSExercise of Over-allotment Option
14th Jul 20217:00 amRNSStabilisation Notice
13th Jul 20214:17 pmRNSDirector/PDMR Shareholding
7th Jul 20217:00 amRNSStabilisation Notice
1st Jul 202112:10 pmRNSHolding(s) in Company
1st Jul 202112:08 pmRNSHolding(s) in Company
30th Jun 202112:10 pmRNSTotal Voting Rights
30th Jun 20217:00 amRNSStabilisation Notice
24th Jun 202110:58 amRNSHolding(s) in Company
24th Jun 202110:47 amRNSDirector/PDMR Shareholding - Correction
23rd Jun 20212:35 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSStabilisation Notice
21st Jun 202110:21 amRNSDirector/PDMR Shareholding
21st Jun 202110:15 amRNSHolding(s) in Company
21st Jun 20218:00 amRNSAdmission to Trading
17th Jun 202111:03 amRNSBlock Listing Application
16th Jun 20211:26 pmRNSApproval and Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.